Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
2003 1
2005 2
2006 2
2010 1
2011 2
2012 1
2016 1
2017 2
2018 1
2019 1
2020 3
2021 3
2022 6
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
A multi-laboratory preclinical trial in rodents to assess treatment candidates for acute ischemic stroke.
Lyden PD, Diniz MA, Bosetti F, Lamb J, Nagarkatti KA, Rogatko A, Kim S, Cabeen RP, Koenig JI, Akhter K, Arbab AS, Avery BD, Beatty HE, Bibic A, Cao S, Simoes Braga Boisserand L, Chamorro A, Chauhan A, Diaz-Perez S, Dhandapani K, Dhanesha N, Goh A, Herman AL, Hyder F, Imai T, Johnson CW, Khan MB, Kamat P, Karuppagounder SS, Kumskova M, Mihailovic JM, Mandeville JB, Morais A, Patel RB, Sanganahalli BG, Smith C, Shi Y, Sutariya B, Thedens D, Qin T, Velazquez SE, Aronowski J, Ayata C, Chauhan AK, Leira EC, Hess DC, Koehler RC, McCullough LD, Sansing LH. Lyden PD, et al. Among authors: diaz perez s. Sci Transl Med. 2023 Sep 20;15(714):eadg8656. doi: 10.1126/scitranslmed.adg8656. Epub 2023 Sep 20. Sci Transl Med. 2023. PMID: 37729432 Clinical Trial.
Aberrant B-cell activation and B-cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment.
Morales-Núñez JJ, Muñoz-Valle JF, García-Chagollán M, Cerpa-Cruz S, Martínez-Bonilla GE, Medina-Rosales VM, Díaz-Pérez SA, Nicoletti F, Hernández-Bello J. Morales-Núñez JJ, et al. Among authors: diaz perez sa. Clin Exp Immunol. 2023 Dec 13;214(3):314-327. doi: 10.1093/cei/uxad076. Clin Exp Immunol. 2023. PMID: 37464892
Alteration of Fermentative Metabolism Enhances Mucor circinelloides Virulence.
Díaz-Pérez SP, Patiño-Medina JA, Valle-Maldonado MI, López-Torres A, Jácome-Galarza IE, Anaya-Martínez V, Gómez-Ruiz V, Campos-García J, Nuñez-Anita RE, Ortiz-Alvarado R, Ramírez-Díaz MI, Gutiérrez-Corona JF, Meza-Carmen V. Díaz-Pérez SP, et al. Infect Immun. 2020 Jan 22;88(2):e00434-19. doi: 10.1128/IAI.00434-19. Print 2020 Jan 22. Infect Immun. 2020. PMID: 31685547 Free PMC article.
The Stroke Preclinical Assessment Network: Rationale, Design, Feasibility, and Stage 1 Results.
Lyden PD, Bosetti F, Diniz MA, Rogatko A, Koenig JI, Lamb J, Nagarkatti KA, Cabeen RP, Hess DC, Kamat PK, Khan MB, Wood K, Dhandapani K, Arbab AS, Leira EC, Chauhan AK, Dhanesha N, Patel RB, Kumskova M, Thedens D, Morais A, Imai T, Qin T, Ayata C, Boisserand LSB, Herman AL, Beatty HE, Velazquez SE, Diaz-Perez S, Sanganahalli BG, Mihailovic JM, Hyder F, Sansing LH, Koehler RC, Lannon S, Shi Y, Karuppagounder SS, Bibic A, Akhter K, Aronowski J, McCullough LD, Chauhan A, Goh A; SPAN Investigators. Lyden PD, et al. Among authors: diaz perez s. Stroke. 2022 May;53(5):1802-1812. doi: 10.1161/STROKEAHA.121.038047. Epub 2022 Mar 31. Stroke. 2022. PMID: 35354299 Free PMC article. Clinical Trial.
Efficacy and Safety of Heterologous Booster Vaccination after Ad5-nCoV (CanSino Biologics) Vaccine: A Preliminary Descriptive Study.
Muñoz-Valle JF, Sánchez-Zuno GA, Matuz-Flores MG, Hernández-Ramírez CO, Díaz-Pérez SA, Baños-Hernández CJ, Turrubiates-Hernández FJ, Vega-Magaña AN, Hernández-Bello J. Muñoz-Valle JF, et al. Among authors: diaz perez sa. Vaccines (Basel). 2022 Mar 5;10(3):400. doi: 10.3390/vaccines10030400. Vaccines (Basel). 2022. PMID: 35335032 Free PMC article.
The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells.
Nickols NG, Ganapathy E, Nguyen C, Kane N, Lin L, Diaz-Perez S, Nazarian R, Mathis C, Felix C, Basehart V, Zomorodian N, Kwak J, Kishan AU, King CR, Kupelian PA, Rettig MB, Steinberg ML, Cao M, Knudsen BS, Chu FI, Romero T, Elashoff D, Reiter RE, Schaue D. Nickols NG, et al. Among authors: diaz perez s. Prostate Cancer Prostatic Dis. 2021 Mar;24(1):135-139. doi: 10.1038/s41391-020-0249-8. Epub 2020 Jul 9. Prostate Cancer Prostatic Dis. 2021. PMID: 32647353 Free PMC article. Clinical Trial.
Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies.
Morales-Núñez JJ, Muñoz-Valle JF, Machado-Sulbarán AC, Díaz-Pérez SA, Torres-Hernández PC, Panduro-Espinoza BV, Gallegos-Díaz de Leon JA, Munguía-Ramirez CD, Hernández-Bello J. Morales-Núñez JJ, et al. Among authors: diaz perez sa. Immunol Lett. 2022 Dec;251-252:20-28. doi: 10.1016/j.imlet.2022.10.002. Epub 2022 Oct 21. Immunol Lett. 2022. PMID: 36279685 Free PMC article.
33 results